Early initiation of low-dose gilteritinib maintenance improves posttransplant outcomes in patients with R/R FLT3mut AML.
Terao T, Matsuoka KI, Ueda H, Matsumura A, Matsubara C, Kondo K, Kondo T, Fujiwara H, Asada N, Ennishi D, Nishimori H, Fujii K, Fujii N, Maeda Y.
Terao T, et al. Among authors: ueda h.
Blood Adv. 2023 Mar 14;7(5):681-686. doi: 10.1182/bloodadvances.2022008991.
Blood Adv. 2023.
PMID: 36583677
Free PMC article.
No abstract available.